NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

AIDS Vaccine Week


Susan Hasty, Publisher
Table of Contents . . . January 5th, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in AIDS Vaccine Week | Other Publications

HIV/AIDS - Data from S.P. Buchbinder and colleagues advance knowledge in HIV/AIDS

HIV/AIDS - Data on HIV/AIDS described by M.L. Precopio et al

HIV/AIDS - New HIV/AIDS study findings recently were reported by researchers at McMaster University

HIV/AIDS - New HIV/AIDS study results reported from M.J. Mcelrath et al

 HIV/AIDS - Recent studies from University of California add new data to HIV/AIDS

HIV/AIDS - Recent studies from University of Wisconsin add new data to HIV/AIDS

Life Sciences - National Institutes of Health publishes research in life sciences

HIV/AIDS Vaccines - Scientists at Swedish Institute for Infectious Disease Control release new data on HIV/AIDS vaccines

Cancer Vaccines - ImQuest Presentations at International HIV Meeting Highlight Significant Progress in Their Therapeutic and Microbicide Development Programs

HIV/AIDS - The International AIDS Vaccine Initiative Posts $150,000 Challenge on InnoCentive in Search of New Approaches to AIDS Vaccine Design


Return to Top of Page

-----------------------
Home | Free Newsletters | Products | Article Library | About Us | Contact | Privacy Policy | Search | Visit VerticalNews.com
Copyright © 2009 NewsRx		 PR Login